The two main themes of this symposium centre on the roles played by the intracellular and extracellular parts of the CD45 antigen. The intracellular part has been characterized as a protein tyrosine phosphate phosphatase with an important role in lymphocyte activation. The extracellular part shows antigenic heterogeneity that has been of value in the recognition of subpopulations of lymphocytes, and in particular in dividing CD4-positive T lymphocytes into functional subsets. Interestingly two of the other markers that have been used to subdivide this population were, like CD45, originally defined with alloantisera namely the Thy-1 [ 11 and RT-6 [peripheral thymus-derived antigen (Pta)] antigens [Z].
Introduction to CD45
The family of antigens now known as CD45 was originally defined with alloantisera in mice as the Ly-5 antigens [3] and in rat as the ART-1 [4] and Ly-1 antigens [5] . There has been some confusion in the literature because on the basis of cytotoxicity assays these antisera were thought to be T-cell specific [4] but are now known to recognize CD45 because both binding and cytotoxic assays for these reagents can be inhibited by purified CD45 [6] . In the period before the introduction of monoclonal antibodies (mAb), CD45 had been recognized by rabbit antisera raised against lymphocytes as an [7] , and a similar sized band on all rat leucocytes and named leucocyte common antigen (LCA) [8, 91. The use of mAbs confirmed that these were all the same family of glycoproteins and that there was genuine variation in apparent M,, glycosylation and antigenicity (reviewed in [ 101).
Biochemical characterization of CD45
The sequence of rat CD45 was determined by using peptide sequences from purified antigen to design oligonucleotides, which in turn were used to screen cDNA libraries [ l l ] ; mouse CD45 was cloned by a subtractive cDNA library approach in which putative cDNA clones were tested by Southern blot analysis to see whether they detected restriction-fragment polymorphisms consistent with the alleles of Ly-5 [12] . The sequence of rat CD45 showed that it was a transmembrane glycoprotein with a single transmembrane segment and a cytoplasmic region of 705 amino acids, which could be subdivided into two domains with sequence similarities [ 111. This is one of the largest cytoplasmic regions found in transmembrane proteins to date. At that time CD45 showed no sequence similarity to any known proteins, but showed strong similarities to a placental tyrosine phosphate phosphatase when its sequence was determined [ 131. It is now clear that CD45 contains two domains with sequence similarity to this and other phosphatases and phosphatase activity has been shown for CD45 [14] . This is discussed in detail in other parts of this symposium.
I62
CD45 shows cell-specific variation in molecular mass, antigenicity and glycosylation [lo] . mAbs recognizing restricted epitopes of CD45 have been used to distinguish phenotypic and functional subsets of lymphocytes in several species [15] [16] [17] [18] . The sequence of CD45 cDNA clones from various cell sources from rat, mouse and human provided an explanation for the heterogeneity in M, which was in part shown to be caused by the selective utilization of three extra exons that are expressed in various combinations and numbers (reviewed in Thomas et al. [ 111) . mAbs that react with a subfraction of human and mouse CD45 have been shown to recognize the products of exons A and B [ 19,201. In addition to the heterogeneity caused by alternative exon usage there is evidence of different glycosylation patterns on CD45 from B and T cells [21] .
Expression of soluble forms of CD45 and analysis of restricted epitopes
The expression of soluble forms of CD45 was attempted in order to map the epitopes recognized by the CD45 mAbs that react with subsets of rat leucocytes, and also to provide large amounts of material for biochemical studies and attempts to characterize the ligands for CD45 isoforms. The expression system used was one that had been used to successfully produce large amounts of soluble forms of the CD4 antigen [22] . In this system the gene of interest is expressed in Chinese hamster ovary cells after transfection with a vector which directs expression from a human cytomegalovirus promoter and selection is based on the inhibition of glutamine synthetase by methionine sulphoximine. The extracellular portions for four different isoforms of rat CD45 were expressed; these contained sequences corresponding to either all three alternative exons (sCD45.ABC), the B exon (sCD45.B), the C exon (sCD45.C), or no exons (sCD45.0). The sCD45 forms were purified by mAb affinity chromatography. The various forms wre checked for their ability to inhibit radioactive-binding assays using anti-CD45 mAbs. The MRC OX-22 mAb has been widely used to split rat CD4' T cells into functionally distinct subpopulations [ 17, 23, 241 . It was mapped to the product of exon C because only the CD45.ABC and CD45.C forms inhibited its binding (not shown). There has been considerable confusion as to the nature of this epitope as it had been partially mapped by peptide analysis. The OX-22 epitope is not affected by reduction and alkylation or trypsin digestion allowing purification of an antigenic tryptic peptide from rat spleen CD45 [25] . Only a partial sequence was obtained that corresponded to the middle of the B exon [26] .
However, it was not known whether the peptide continued through the C exon or went directly to the constant part of the CD45. The possible peptides are illustrated in Fig. 1 although it is not clear whether trypsin cleaves at the Arg reside shown as the next residue is probably N-glycosylated which may inhibit cleavage. In this case the peptide will extend through into the common region and a peptide with such a composition has been obtained [27] . However, cleavage probably can occur here as the OX-32 determinant which is also dependent on the C exon is trypsin sensitive. The OX-22 epitope is presumably within the region shown in Fig. 1 and it is notable that there are considerable differences in this part of the sequence between rat and mouse with far fewer in the remainder of the exon (Fig. 2) .
The functional properties of cells separated on the basis of the expression of the C exon are discussed in detail in other papers presented at this symposium. It appears that the expression of exon C leads to a labelling pattern and functional subpopulations very similar to that of the exon B-specific reagents in the mouse and human systems [28] . The OX-33 mAb that labels rat B cells [29] was found to react only with sCD45.ABC 
Localization of the OX-22 epitope by peptide sequence and antigenic analysis of soluble isoforms of CD45
As only a partial sequence was obtained for the OX-22-positive tryptic peptide it is not known whether it was derived from the form including the B exon alone (below) or B and C exons (above). As it is known that the epitope required the C exon the peptide must have been derived from the top form. It is not clear whether trypsin will cleave at the Arg shown, as the next residue is probably Nglycosylated which may inhibit cleavage. In this case the peptide will extend through into the common region and a peptide with such a composition has been obtained [27] . , , , , , , , , , , , , , , , , , I 4 Sequence of OX-22 peptide -4
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Fig. 3
A schematic view of CD45, CD4 and CD43 (Leukosialin) at the cell surface
The size of CD43 is based on studies by electron microscopy. CD45 is based on electron microscopy of the thymocyte form that expresses only the smallest isoform, and the size of the extra segments coded by the alternatively spliced exons is estimated from the dimensions of CD43 which is likely t o have a similar highly glycosylated structure (see text). The dimensions of CD4 are based on the structure determined for the first two implying that it reacts with the product of the A exon or the junction of the A and B exons. However, unlike the anti-A-exon product in humans, the OX-33 does not react with T cells. It is not clear whether this is a genuine difference in the expression of the A exon or whether the OX-33 reagent does not recognize all of the products containing the A exon. This is possible, because the OX-33 mAb labels all B cells but does not pull out all the high-molecular-mass material on B cells by antibody affinity chromatography of solubilized B-cell membranes [29] .
Topography of CD45 antigens at the cell surface
Electron microscopy of CD45 antigen purified from thymocytes indicated that the extracellular part formed a rod of length of about 28 nm together with a globular domain of about 12 nm diameter which contains the cytoplasmic domain [30] . The thymocyte form of CD45 is almost entirely of the smallest CD45.0 form lacking the three alternatively spliced exons [26] . The sequence encoded by these exons is unusual in that there is a total lack of cysteine, a few hydrophobic residues and a high content of Ser, Thr and Pro [26] . This is often found in regions that have a high content of 0-linked sugars and this is the case for at least part of the extra sequence [27] . The only part of the remainder of CD45 that has any 0-linked sugars is a short segment near the N-terminus [26] . One consequence of this type of sequence is that it is unlikely to be tightly folded and could form an extended structure. The CD43 antigen has a similar composition with extensive 0-linked sugars where electron microscopy indicates an elongated structure with approximately 0.2 nm per amino acid [31] . Figure 3 shows 
